skip navigational links Occupational Safety & Health Administration DOL.gov OSHA.gov DOL.gov
www.OSHA.gov
o-Dichlorobenzene Chemical Sampling Information
o-Dichlorobenzene

General Description
    Synonyms: o-DCB; 1,2-Dichlorobenzene; ortho-Dichlorobenzene; o-Dichlorobenzol

    OSHA IMIS Code Number: 0867

    Chemical Abstracts Service (CAS) Registry Number: 95-50-1

    NIOSH, Registry of Toxic Effects (RTECS) Identification Number: CZ4500000

    Department of Transportation Regulation Number (49 CFR 172.101) and Guide: 1591 152

    NIOSH Pocket Guide to Chemical Hazards, o-Dichlorobenzene: chemical description, physical properties, potentially hazardous incompatibilities, and more
Exposure Limits
    OSHA Permissible Exposure Limit (PEL) for General Industry: 29 CFR 1910.1000 Z-1 Table -- 50 ppm, 300 mg/m3 Ceiling

    OSHA Permissible Exposure Limit (PEL) for Construction Industry: 29 CFR 1926.55 Appendix A -- 50 ppm, 300 mg/m3 Ceiling

    OSHA Permissible Exposure Limit (PEL) for Maritime: 29 CFR 1915.1000 Table Z-Shipyards -- 50 ppm, 300 mg/m3 Ceiling

    American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value (TLV): 25 ppm, 150 mg/m3 TWA; 50 ppm, 301 mg/m3 STEL; Appendix A4 - Not Classifiable as a Human Carcinogen

    National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Limit (REL): 50 ppm, 300 mg/m3 Ceiling
Health Factors
    International Agency for Research on Cancer (IARC) carcinogenic classification: Group 3, not classifiable as to its carcinogenicity to humans

    NIOSH Immediately Dangerous To Life or Health Concentration (IDLH): 200 ppm

    Potential symptoms: Irritation of eyes, nose; cough, sore throat; dizziness, fatigue, headache, nausea; unconsciousness; liver, kidney damage; skin blisters; INGES. ACUTE: Burning sensation; nausea, vomiting, diarrhea.

    Health Effects: Irritation-Eye, Nose, Throat, Skin---Marked (HE14); Liver damage (HE4); Clastogen (HE2).

    Affected organs: Eyes, skin, respiratory system, liver, kidneys

    Notes:
    1. Urinary metabolites of o-dichloro-benzene include 4,5-dichlorocatechol, 3,4-dichlorocatechol, 2,3-dichlorophenol, and 3,4-dichlorophenol and their conjugates.
    2. The urinary conjugates, 2,3-dichloro-phenylmercapturic acid and 3,4-dichloro-phenylmercapturic acid, were reported to have mean excretion half-lives of 5.3 and 5.9 hours, respectively, in eight volunteers.
    3. The hepatotoxicity of o-dichlorobenzene may be due to production of reactive metabolites, possibly epoxides, which bind covalently to proteins and DNA, as well as to oxidative stress from the intracellular depletion of reduced glutathione (GSH).
    4. Chromosome studies of laboratory workers six months after they were accidentally exposed to o-dichlorobenzene showed four times as many aberrations (single and double strand chromosome breaks) as a control group performing comparable work elsewhere.
    5. Although a case of chloracne was recently attributed to low-level exposure to o-dichlorobenzene, chloracne was not mentioned as one of the symptoms in any of 26 accidentally exposed lab workers.
    6. EPA's oral reference dose (daily oral exposure likely to be without an appreciable risk of deleterious effects during a lifetime) of o-dichlorobenzene is 0.09 mg/kg/day.

    Date Last Revised: 11/07/2005

    Literature Basis:
    • NIOSH Pocket Guide to Chemical Hazards: o-Dichlorobenzene.
    • International Chemical Safety Cards (WHO/IPCS/ILO): 1,2-Dichlorobenzene.
    • U.S. EPA Integrated Risk Information System: 1,2-Dichlorobenzene (CASRN 95-50-1).
    • Hissink, A.M., Van Ommen, B., Krüse, J. and Van Bladeren, P.J.: A physiologically based pharmacokinetic (PB-PK) model for 1,2-dichlorobenzene linked to two possible parameters of toxicity. Toxicol. Appl. Pharmacol. 145(2): 301-310, 1997.
    • Kumagai, S. and Matsunaga, I.: Relations between exposure to o-dichlorobenzene and concentrations of urinary metabolites. J. Occup. Health 39(2): 124-129, 1997.
    • McDougal, J.N., Grabau, J.H., Dong, I., Mattie, D.R. and Jepson, G.W.: Inflammatory damage to skin by prolonged contact with 1,2-dichlorobenzene and chloropentafluorobenzene. Microsc. Res. Tech. 37(3): 214-220, 1997.
    • Pohanish, R.P. (editor): Dichlorobenzenes. In, Sittig's Handbook of Toxic and Hazardous Chemicals and Carcinogens, Fourth Ed., Vol. 1. Norwich, NY: Noyes Publications, William Andrew Publishing, 2002, pp. 799-804.
    • Violante, F.S., Milani, S., Malenchini, G. and Barbieri, A.: Chloracne due to o-dichlorobenzene in a laboratory worker. Contact Dermatitis 52(2): 108, 2005.
    • Zapata-Gayon, C., Zapata-Gayon, N. and Gonzalez-Angulo, A.: Clastogenic chromosomal aberrations in 26 individuals accidentally exposed to ortho dichlorobenzene vapors in the National Medical Center in Mexico City. Arch. Environ. Health 37(4): 231-235, 1982.
    • Zenser, L.-P., Lang, A. and Knecht, U.: N-Acetyl-S-(dichlorophenyl)cysteines as suitable biomarkers for the monitoring of occupational exposure to 1,2-dichlorobenzene. Int. Arch. Occup. Environ. Health 69(4): 252-254, 1997.
Monitoring Methods used by OSHA
    Laboratory Sampling/Analytical Method:

    • sampling media: Charcoal Tube (100/50 mg sections, 20/40 mesh)
      analytical solvent: Carbon Disulfide
      minimum time: 15 Minutes   maximum flow rate: 0.2 L/min (Ceiling)
      current analytical method: Gas Chromatography; GC/FID
      method reference: NIOSH Analytical Method (NIOSH 1003)
      method classification: Partially Validated
* All Trademarks are the property of their respective owners.

 Safety and Health
 Topics
 
  Chemical Sampling Information:
  o-Dichlorobenzene
  General Description
  Exposure Limits
  Health Factors
  Monitoring
     
 
 
Page last updated: 09/05/2006

Accessibility Assistance
Contact the OSHA Directorate of Science, Technology and Medicine at 202-693-2300 for assistance accessing PDF materials.
Back to Top Back to Top www.osha.gov www.dol.gov

Contact Us | Freedom of Information Act | Customer Survey
Privacy and Security Statement | Disclaimers
Occupational Safety & Health Administration
200 Constitution Avenue, NW
Washington, DC 20210